Persistent monoclonality after histological remission in gastric mucosa-associated lymphoid tissue lymphoma treated with chemotherapy and/or surgery: Influence of t(11;18)(q21;q21)

References

• Wotherspoon A C, Doglioni C, Diss T C, Pan L, Moschini A, de Boni M, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342: 575–577
   PubMed Web of Science ®Google Scholar
• Bayerdorffer E, Neubauer A, Rudolph B, Thiede C, Lehn N, Eidt S, et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. Lancet 1995; 345: 1591–1594
   PubMed Web of Science ®Google Scholar
• Roggero E, Zucca E, Pinotti G, Pascarella A, Capella C, Savio A, et al. Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue. Ann Intern Med 1995; 122: 767–769
   PubMed Web of Science ®Google Scholar
• Montalban C, Santon A, Boixeda D, Redondo C, Alvarez I, Calleja J L, et al. Treatment of low-grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histological and molecular follow-up. Haematologica 2001; 86: 609–617
   PubMed Web of Science ®Google Scholar
• Thiede C, Wundisch T, Alpen B, Neubauer B, Morgner A, Schmitz M, et al. Long-term persistence of monoclonal B cells after cure of Helicobacter pylori infection and complete histological remission in gastric mucosa-associated lymphoid tissue B-cell lymphoma. J Clin Oncol 2001; 119: 1600–1609
   Google Scholar
• Montalban C, Santon A, Redondo C, Garcia-Cosio M, Boixeda D, Vazquez-Sequeiros E, et al. Long-term persistence of molecular disease after histological remission in low grade gastric MALT lymphoma treated with H. pylori eradication. Lack of association with translocation t(11;18)(q21;q21): a 10-year updated follow-up of a prospective study. Ann Oncol 2005; 16: 1539–1544
   PubMed Web of Science ®Google Scholar
• Wundisch T, Thiede C, Morgner A, Dempfle A, Gunther A, Liu H, et al. Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. J Clin Oncol 2005; 23: 8018–8024
   PubMed Web of Science ®Google Scholar
• Fischbach W, Goebeler-Kolve M E, Dragosics B, Greiner A, Stolte M. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series. Gut 2004; 53: 34–37
   PubMed Web of Science ®Google Scholar
• Liu H, Ye H, Ruskone-Fourmestraux A, De Jong D, Pileri S, Thiede C, et al. T(11;18)(q21;q21) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology 2002; 122: 1286–1294
   PubMed Web of Science ®Google Scholar
• Fischbach W, Dragosics B, Kolve-Goebeler M E, Ohmann C, Greiner A, Yang Q, et al. Primary gastric B-cell lymphoma: results of a prospective multicenter study. Gastroenterology 2000; 119: 1191–1202
   PubMed Web of Science ®Google Scholar
• Tsang R W, Gospodarowicz M K, Pintilie M, Wells W, Hodgson D C, Sun A, et al. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. J Clin Oncol 2003; 22: 4157–4164
   Web of Science ®Google Scholar
• Schechter N, Portlock C S, Yahalom J. Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone. J Clin Oncol 1998; 16: 1916–1921
   PubMed Web of Science ®Google Scholar
• Koch P, Probst A, Berdel W E, Willich N A, Reinartz G, Brockmann J, et al. Treatment results in localized primary gastric lymphoma: data of patients registered within the german multicenter study (GIT NHL 02/96). J Clin Oncol 2005; 23: 7050–7059
   PubMed Web of Science ®Google Scholar
• Hammel P, Haioun C, Chaumette M T, Gaulard P, Divine M, Reyes F, et al. Efficacy of single agent chemotherapy in low grade B-cell mucosa-associated lymphoid tissue lymphoma with prominent gastric expression. J Clin Oncol 1995; 13: 2524–2529
   PubMed Web of Science ®Google Scholar
• Jäger G, Neumeister P, Brezinschek R, Hinterleitner T, Fiebiger W, Penz M, et al. Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT)-type with Cladribine (2-Chlorodeoxyadenosine): a phase II study. J Clin Oncol 2002; 18: 3872–3877
   Web of Science ®Google Scholar
• Wohrer S, Drach J, Hejna M, Scheithauer W, Dirisamer A, Puspok A, et al. Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) with mitoxantrone, chlorambucil and prednisone (MCP). Ann Oncol 2003; 14: 1758–1761
   PubMed Web of Science ®Google Scholar
• Martinelli G, Laszlo D, Ferreri A J, Pruneri G, Ponzoni M, Conconi A, et al. Clinical activity of rituximab in gastric marginal zone lymphoma non-Hodgkin's lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy. J Clin Oncol 2005; 23: 1979–1983
   PubMed Web of Science ®Google Scholar
• Noy A, Yahalom J, Zaretsky L, Brett I, Zelenetz D. Gastric mucosa-associated lymphoid tissue lymphoma detected clonotypic polymerase chain reaction despite continuous pathologic remission induced by involved-field radiotherapy. J Clin Oncol 2005; 23: 3768–3772
   PubMed Web of Science ®Google Scholar
• Alpen B, Kuse R, Parwaresch R, Muller-Hermelink H K, Stolte M, Neubauer A. Ongoing monoclonal B-cell proliferation is not common in gastric B-cell lymphoma after combined radiochemotherapy. J Clin Oncol 2004; 22: 3039–3045
   PubMed Web of Science ®Google Scholar
• Isaacson P G, Muller-Hermelink H K, Piris M A, Berger F, Nathwani B N, Swerdlow S H, . Extranodal marginal zone B-cell lymphoma of mucosa associated lymphoid tissue (MALT) lymphoma. Tumours of Haematopoietic and Lymphoid Tissues: World Health Organization Classification of tumours, E S Jaffe, N L Harris, H Stem, J W Vardiman, et al. IARC Press, Lyon 2001; 157–160
   Google Scholar
• Rohatiner A, d'Amore F, Coiffier B, Crowther D, Gospodarowicz M, Isaacson P, et al. Report of a workshop convened to discuss the pathological staging classification of gastrointestinal tract lymphoma. Ann Oncol 1994; 5: 397–400
   PubMed Web of Science ®Google Scholar
• Zhou X G, Sandve K, GregersenN, Hamilton-Dutoit S J. Detection of clonal B cells in microdissected reactive lymphoproliferations: possible diagnostic pitfalls in PCR analysis of immunoglobulin heavy chain gene rearrangement. J Clin Pathol: Mol Pathol 1999; 52: 104–110
   Web of Science ®Google Scholar
• Salar A, Bellosillo B, Serrano S, Besses C. Persistent residual disease in t(11;18)(q21;q21) positive gastric mucosa-associated lymphoid tissue lymphoma treated with chemotherapy or rituximab. J Clin Oncol 2005; 23: 7361–7362
   PubMed Web of Science ®Google Scholar
• Streubel B, Huber D, Wohrer S, Chott A, Raderer M. Reverse transcription-PCR for t(11;18)(q21;q21) detection in mucosa-associated lymphoid tissue lymphoma. Clin Cancer Res 2006; 12: 6028–6032
   Web of Science ®Google Scholar
• Lenze D, Greiner A, Knorr C, Anagnostopoulos I, Stein H, Hummel M. Receptor revision of immunoglobulin heavy chain genes in human MALT lymphomas. J Clin Pathol: Mol Pathol 2003; 56: 249–255
   PubMed Web of Science ®Google Scholar
• Starostik P, Patzner J, Greiner A, Schwarz S, Kalla J, Ott G, et al. Gastric marginal zone B-cell lymphomas of MALT type develop along 2 distinct pathogenetic pathways. Blood 2002; 99: 3–9
   PubMed Web of Science ®Google Scholar
• Farinha P, Gascoyne R. Molecular pathogenesis of mucosa-associated lymphoid tissue lymphoma. J Clin Oncol 2005; 23: 6370–6378
   PubMed Web of Science ®Google Scholar